Tue.Jul 18, 2023

article thumbnail

From rapid cooling body bags to ‘prescriptions’ for AC, doctors prepare for a future of extreme heat

STAT

In Phoenix, where daytime temperatures are topping 110 degrees Fahrenheit for the third straight week, emergency room doctors think of extreme heat as the public health emergency it has proved itself to be: In 2022, Arizona’s Maricopa County reported a 25% increase in heat-related mortality from the previous year. “Heat is just something we know we need to be really worried about,” said Geoff Comp, an emergency medicine physician at Valleywise Health Medical Center.

Hospitals 246
article thumbnail

Threads joins the social media fray. Here’s what it means for pharma marketers

PharmaVoice

Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Flagship, Pfizer team up in deal worth up to $7 billion

STAT

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies. Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties.

article thumbnail

What the 2014 Ebola outbreak taught this biotech CEO about persuasion

PharmaVoice

A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A new study shows how Medicaid coverage policies shape maternal health disparities

STAT

Medicaid is an essential source of maternal and postpartum care for low-income Americans, covering 42% of births in the U.S. People who give birth receive maternity care until at least two months after delivery, or longer depending on state or local policies. But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 201

233
233
article thumbnail

Pfizer, Flagship join forces to hunt for 10 new drugs

BioPharma Dive

The unusual research alliance involves the startup creator’s Pioneering Medicines initiative, which previously struck pacts with Novo Nordisk and the Cystic Fibrosis Foundation.

98

More Trending

article thumbnail

MHRA consults on making codeine linctus prescription-only medication

The Pharmacist

Codeine linctus could become a prescription-only medication (POM) under new proposals from the Medicines and Healthcare Products Regulatory Agency (MHRA). This follows ‘multiple reports’ that the cough suppressant is being used recreationally for its opioid effects. The MHRA has asked the public to share their opinions on how codeine linctus should be classified in a […] The post MHRA consults on making codeine linctus prescription-only medication appeared first on The Pharmacist.

92
article thumbnail

STAT+: As digital health tech proliferates, a new institute aims to cut through hype

STAT

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle. The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday.

226
226
article thumbnail

Time-restricted eating 'no better' than calorie counting for weight loss in obese adults

The Pharmacist

A time-restricted eating pattern without focusing on lowering calorie intake is no better than a reduced calorie diet for weight loss among obese adults, according to a recent randomised trial. The timing of food intake appears to impact on the success of weight-loss therapy. In fact, it is already known that an early time-restricting feeding […] The post Time-restricted eating 'no better' than calorie counting for weight loss in obese adults appeared first on The Pharmacist.

86
article thumbnail

Opinion: AI can’t replicate this key part of practicing medicine

STAT

I’ve heard “WebMD said it could be cancer” countless times in my 15 years working as an emergency medicine physician. I get it: When someone is feeling unwell or hoping a worrying symptom will go away, it makes sense for them to turn to easily accessible resources. As people become increasingly familiar with artificial intelligence platforms like ChatGPT, it’s only a matter of time before patients turn to these tools in search of a diagnosis or second opinion.

Hospitals 217
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.

article thumbnail

STAT+: At Orexo, a ‘turning point’ for everything but digital health

STAT

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline. The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acti

Packaging 215
article thumbnail

Drug Solutions Podcast: Evaluating the Vaccine Marketplace

PharmaTech

Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.

article thumbnail

STAT+: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill

STAT

WASHINGTON — Senate health committee Chair Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Only one of them, however, would grant the Food and Drug Administration new authorities to tackle the issue. Congress is under pressure to stem drug shortages amid reports of doctors rationing chemotherapies and other essential medicines.

article thumbnail

ADDF reflects on Eli Lilly’s donanemab

Pharma Times

Company’s phase 3 research showed the importance of running biomarker-powered clinical trials - News - PharmaTimes

107
107
article thumbnail

STAT Virtual Event: The State of Biosimilars: What to Watch

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

article thumbnail

Threads, the Twitter Competitor's Impact on Pharma Marketing: Q&A with Justin Chase

PharmExec

An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.

97
article thumbnail

STAT+: Medicare has a new plan to address drug shortages — but it could backfire

STAT

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid. For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power.

Hospitals 200
article thumbnail

A cancer biotech’s collapse gives Neurogene a path to Wall Street

BioPharma Dive

The startup, a developer of gene therapies for brain diseases like Rett Syndrome, will bypass an IPO by merging with struggling cancer drugmaker Neoleukin.

98
article thumbnail

STAT+: Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs

STAT

Rise and shine, everyone, another busy day is on the way. We can tell because our shortest person has dashed off to a local educational institution in a hurry and the mascots are bounding about our sandlot. As for us, we are up to the usual. We are brewing cups of stimulation — our choice this morning is chocolate cappuccino —and foraging for items of interest.

Hospitals 197
article thumbnail

Scribe and Sanofi expand genetic therapy development deal

Pharmaceutical Technology

Scribe Therapeutics and Sanofi have expanded partnership to progress the development of in vivo genetic therapies to treat genomic diseases.

98
article thumbnail

STAT+: Startup Neumora takes a novel depression drug to Phase 3

STAT

Neumora, a privately held biotech company, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial. The drug, a daily pill called navacaprant, led to statistically significant improvements over placebo on a measurement of disease severity for patients with moderate to severe major depressive disorder, Neumora said Tuesday.

192
192
article thumbnail

Chemspace and Arrayjet link up to boost drug discovery

Pharma Times

The partnership will expand Arrayjet’s small molecule microarray drug discovery offerings - News - PharmaTimes

99
article thumbnail

STAT+: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing

STAT

For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in the process, bringing discredit on the entire pharmaceutical industry. In the latest instance, the company was cited for making unsubstantiated and spurious claims in a podcast that was promoting the Entresto heart failure medication to nurses.

191
191
article thumbnail

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The Guardian - Pharmaceutical Industry

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution ‘I speak as a healthcare CEO, but also as a nature lover and as a grandfather,” Pascal Soriot, chief executive of Britain’s biggest drugmaker, AstraZeneca, told King Charles III and a select audience during London Climate Week at an event in the gothic grandeur of Guildhall.

article thumbnail

EU prepares for the winter with plans to avoid an antibiotic shortage

Pharmaceutical Technology

The EC, the Heads of Medicines Agencies (HMA), and the EMA have issued recommendations to prevent shortages of antibiotics.

97
article thumbnail

Four Crucial Questions about the Humira Biosimilar Price War

Drug Channels

The Humira biosimilar market has arrived! This month, nine biosimilar versions of adalimumab launched in the U.S. market. As I predicted in 2021 , some products launched with list prices that are only slightly lower than Humira’s list price, while others are trying to tempt payers and pharmacy benefit manages (PBMs) with deep list price discounts. Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies.

article thumbnail

BridgeBio Pharma’s heart disease drug meets main goal in late-stage study

Express Pharma

The company said no safety concerns were identified in patients, adding that it intends t submit marketing applications to the US Food and Drug Administration before the end o 2023, with regulatory filings in additional markets to follow in 2024 BridgeBio Pharma Inc said on Monday its experimental drug to treat a kind of heart disease showed statistically significant improvement in reducing hospitalisations in a late-stage study, sending shares up 64 per cent.

78
article thumbnail

Roche licenses drug to target cancer DNA damage response

Outsourcing Pharma

Roche has entered a licensing and collaboration deal with the U.S. company KSQ Therapeutics to co-develop KSQâs lead cancer drug, which is designed to sabotage the DNA repair mechanisms of cancer cells.

74
article thumbnail

From precision medicine to precision skin health: Verily and L’Oréal announce collaborative study

pharmaphorum

From precision medicine to precision skin health: Verily and L’Oréal announce collaborative study Mike.

96
article thumbnail

Convatec to manufacture new infusion set for with Tandem Diabetes Care

Outsourcing Pharma

Convatec Group, a medical products and technologies company focused on chronic conditions, has partnered with Tandem Diabetes Care on a new five-inch infusion set for Tandem Mobi, the worldâs smallest durable automated insulin delivery system.

article thumbnail

Pfizer inks $7bn strategic level R&D deal with Flagship

pharmaphorum

Pfizer inks $7bn strategic level R&D deal with Flagship Phil.

90
article thumbnail

Washington Representatives Summer Meeting Overview

Putting Patients First Blog

Washington Representatives Summer Meeting Overview July 18, 2023 By: Allen Pinn, Coordinator, Policy After much anticipation, the NHC held its inaugural Washington Representatives Summer meeting at Top of the Hill (TOTH) in Washington, DC. The meeting gathered nearly 100 NHC members across the health care stakeholder community who work in policy and government affairs.

article thumbnail

Transforming US healthcare into a whole person care system

pharmaphorum

Transforming US healthcare into a whole person care system Mike.

89
article thumbnail

Net Patient Score (NPS) in Healthcare

Viseven

Patient satisfaction plays a crucial role in the healthcare industry. The ability to deliver exceptional care experiences is not only essential for improving patient outcomes but also for building long-term relationships and loyalty. Healthcare organizations increasingly turn to the Net Promoter Score (NPS), a widely adopted metric in various industries, to gauge patient satisfaction and loyalty.